太阳集团tyc5997_平台(china)官方网站

激肽释放酶原(PK)真核蛋白

Eukaryotic Prekallikrein (PK)

KLKB1; KLK3; Fletcher Factor; Kallikrein B,Plasma; Kininogenin; Plasma prekallikrein

  • 激肽释放酶原(PK)真核蛋白 产品包装(模拟)
  • 激肽释放酶原(PK)真核蛋白 产品包装(模拟)
  • EPB801Ra61.jpg Figure. SDS-PAGE
  • Certificate 通过ISO 9001、ISO 13485质量体系认证

序列

用法

Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

储存

避免反复冻融。2-8°C不超过一个月,-80°C不超过12个月。

稳定性

热稳定性以损失率显示。损失率是由加速降解试验决定,具体方法如下:在37°C孵育48小时,没有显著的降解或者沉淀产生。保质期内,在适当的条件下存储,损失率低于5%。

相关产品

编号 适用物种:Rattus norvegicus (Rat,大鼠) 应用(仅供研究使用,不用于临床诊断!)
EPB801Ra61 激肽释放酶原(PK)真核蛋白 Positive Control; Immunogen; SDS-PAGE; WB.

参考文献

杂志 参考文献
Int J Immunopathol Pharmacol Altered activities of kininase II, an angiotensin converting enzyme, prekallikrein, and nitric oxide in Kuwaiti patients with type 2 diabetes [PubMed: 25964383]
Thromb Res Factor XII–mediated contact activation related to poor prognosis in disseminated intravascular coagulation [PubMed: 26706311]
Thrombosis Research Factor XII-mediated contact activation related to poor prognosis in disseminated intravascular coaCavia (Guinea pig )lation [Pubmed:26706311]
Annals of Laboratory Medicine The First Case of Congenital Prekallikrein Deficiency in Korea With a Novel Pathogenic Variant (c. 1198G> T) [Pubmed: 30430790]
J Cell Mol Med Huaier shows anti©\cancer activities by inhibition of cell growth, migration and energy metabolism in lung cancer through PI3K/AKT/HIF©\1¦Á pathway [33377619]
J Thromb Thrombolysis Contact system activation in disseminated intravascular coagulation: activities of prekallikrein and high-molecular-weight kininogen are significant risk factors [Pubmed:34993714]
留言咨询
Baidu
sogou